Eyal C. Attar M.D.
Net Worth
Last updated:
What is Eyal C. Attar M.D. net worth?
The estimated net worth of Dr. Eyal C. Attar M.D. is at least $3,993,430 as of 28 Feb 2022. He owns shares worth $74,260 as insider, has earned $137,010 from insider trading and has received compensation worth at least $3,782,160 in Aprea Therapeutics, Inc..
What is the salary of Eyal C. Attar M.D.?
Dr. Eyal C. Attar M.D. salary is $630,360 per year as Senior Vice President & Chief Medical Officer in Aprea Therapeutics, Inc..
How old is Eyal C. Attar M.D.?
Dr. Eyal C. Attar M.D. is 54 years old, born in 1971.
What stocks does Eyal C. Attar M.D. currently own?
As insider, Dr. Eyal C. Attar M.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Aprea Therapeutics, Inc. (APRE) | Senior Vice President & Chief Medical Officer | 47,000 | $1.58 | $74,260 |
What does Aprea Therapeutics, Inc. do?
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products pipeline also includes ATRN-Backup, an ATR inhibitor; ATRN-W1051 to treat anti-tumor activity; and ATRN-DDRi. Aprea Therapeutics, Inc. is based in Boston, Massachusetts.
Eyal C. Attar M.D. insider trading
Aprea Therapeutics, Inc.
Dr. Eyal C. Attar M.D. has made 2 insider trades between 2019-2022, according to the Form 4 filled with the SEC. Most recently he sold 36,000 units of APRE stock worth $62,280 on 28 Feb 2022.
The largest trade he's ever made was exercising 36,000 units of APRE stock on 28 Feb 2022. As of 28 Feb 2022 he still owns at least 47,000 units of APRE stock.
Aprea Therapeutics key executives
Aprea Therapeutics, Inc. executives and other stock owners filed with the SEC:
- Dr. Eyal C. Attar M.D. (54) Senior Vice President & Chief Medical Officer
- Mr. Christian S. Schade (64) Pres, Chief Executive Officer & Chairman
- Mr. Scott M. Coiante (58) Senior Vice President, Company Sec. & Chief Financial Officer